Market Research Logo

Global Hepatic Encephalopathy (HE) Therapeutics Market 2018-2022

Global Hepatic Encephalopathy (HE) Therapeutics Market 2018-2022

About Hepatic Encephalopathy (HE) Therapeutics

HE is a potentially fatal brain disorder that is caused by liver damage, which results in the failure to remove toxins from the blood.

Technavio’s analysts forecast the global hepatic encephalopathy (HE) therapeutics market to grow at a CAGR of 5.35% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global hepatic encephalopathy (HE) therapeutics market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Hepatic Encephalopathy (HE) Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • ASKA Pharmaceutical
  • COSMO PHARMACEUTICALS
  • Mallinckrodt
  • Valeant
Market driver
  • Availability of patient-focused programs to assist disease management
  • For a full, detailed list, view our report
Market challenge
  • Late and inaccurate diagnosis
  • For a full, detailed list, view our report
Market trend
  • Technological advances
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Hepatic Encephalopathy (HE) Therapeutics Market 2018-2022

Technavio recognizes the following companies as the key players in the global hepatic encephalopathy (HE) therapeutics market: ASKA Pharmaceutical, COSMO PHARMACEUTICALS, Mallinckrodt, and Valeant.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is technological advances. The adoption of advanced technology to improve the safety profile of the therapeutics used to treat HE is increasing. For instance, the Multi Matrix (MMX) technology, which is offered by COSMO PHARMACEUTICALS, is one such promising development. The MMX technology helps deliver antibiotics directly into the colon.”

According to the report, one driver in the market is availability of patient-focused programs to assist disease management. Vendors in the market conduct several programs to help patients manage HE. For instance, Salix conducts the Hepatic Encephalopathy Living Program (H.E.L.P.), which provides support to patients and their caregivers to manage HE. H.E.L.P. provides a 24/7 helpline service that is managed by trained nurses to address queries and make reminder calls about medicine refills and doctor visits.

Further, the report states that one challenge in the market is late and inaccurate diagnosis. The symptoms of HE are non-specific. They include personality changes slurred speech, poor coordination, lethargy, confusion, trembling hands, and bad breath. The symptoms are usually subtle and may be attributed incorrectly to other causes. This can cause delays in diagnosis or inaccurate diagnosis. The absence of an agreed standard procedure or diagnostic test is also a challenge that compounds concerns about the diagnosis of the disease.

Companies Mentioned

ASKA Pharmaceutical, COSMO PHARMACEUTICALS, Mallinckrodt, and Valeant.

  • Executive summary
  • Scope of the report
  • Research methodology
  • Introduction
    • Market outline
      • Table Interorgan ammonia metabolism in healthy liver
      • Table WHC classification of HE
      • Table Recommended treatment pathway for HE
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global CNS disorders drugs market: Segments
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Global HE therapeutics market: Segments
  • Market sizing
    • Market definition
      • Table Market definition: Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global HE therapeutics market 2017-2022 ($ millions)
      • Table Global HE therapeutics market: Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition: Five forces 2017
  • Pipeline analysis
    • Table Pipeline landscape by development phase
    • Table Key clinical trials
  • Market segmentation by product
    • Overview
      • Table Global HE therapeutics market: Segmentation by product 2017-2022 (%)
    • Comparison by product
      • Table Comparison by product
    • NADs
      • Table Global NAD HE therapeutics market 2017-2022 ($ millions)
      • Table Global NAD HE therapeutics market: Year-over-year growth 2018-2022 (%)
    • Antibiotics
      • Table Global antibiotic HE therapeutics market 2017-2022 ($ millions)
      • Table Global antibiotic HE therapeutics market: Year-over-year growth 2018-2022 (%)
    • Others
      • Table Global other HE therapeutics market 2017-2022 ($ millions)
      • Table Global other HE therapeutics market: Year-over-year growth 2018-2022 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Market segmentation by disease severity
    • Overview
    • CHE
    • OHE
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global HE therapeutics market: Segmentation by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas
      • Table HE therapeutics market in Americas 2017-2022 ($ millions)
      • Table HE therapeutics market in Americas: Year-over-year growth 2018-2022 (%)
    • EMEA
      • Table HE therapeutics market in EMEA 2017-2022 ($ millions)
      • Table HE therapeutics market in EMEA: Year-over-year growth 2018-2022 (%)
    • APAC
      • Table HE therapeutics market in APAC 2017-2022 ($ millions)
      • Table HE therapeutics market in APAC: Year-over-year growth 2018-2022 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Technological advances
    • Emergence of novel treatment targets
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ASKA Pharmaceutical
      • Table ASKA Pharmaceutical: Overview
      • Table ASKA Pharmaceutical: Business segments
      • Table ASKA Pharmaceutical: Organizational developments
      • Table ASKA Pharmaceutical: Segment focus
      • Table ASKA Pharmaceutical: Key offerings
      • Table ASKA Pharmaceutical: Key customers
    • COSMO PHARMACEUTICALS
      • Table COSMO PHARMACEUTICALS: Overview
      • Table COSMO PHARMACEUTICALS: Business segments
      • Table COSMO PHARMACEUTICALS: Organizational developments
      • Table COSMO PHARMACEUTICALS: Segment focus
      • Table COSMO PHARMACEUTICALS: Key offerings
      • Table COSMO PHARMACEUTICALS: Key customers
    • Mallinckrodt
      • Table Mallinckrodt: Overview
      • Table Mallinckrodt: Business segments
      • Table Mallinckrodt: Organizational developments
      • Table Mallinckrodt: Geographic focus
      • Table Mallinckrodt: Segment focus
      • Table Mallinckrodt: Key offerings
      • Table Mallinckrodt: Key customers
    • Valeant
      • Table Valeant: Overview
      • Table Valeant: Business segments
      • Table Valeant: Organizational developments
      • Table Valeant: Geographic focus
      • Table Valeant: Segment focus
      • Table Valeant: Key offerings
      • Table Valeant: Key customers
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report